Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

29 June 2014: Preliminary Report  

The assessment of sIgA, histatin-5, and lactoperoxidase levels in saliva of adolescents with dental caries

Agnieszka Gornowicz E , Grażyna Tokajuk C , Anna Bielawska D , Elżbieta Maciorkowska A , Robert Jabłoński F , Anna Wójcicka B , Krzysztof Bielawski CE

DOI: 10.12659/MSM.890468

Med Sci Monit 2014; 20:1095-1100

0 Comments

Background

Saliva contains a number of protective factors such as mucins, immunoglobulins (e.g., IgA, IgG, and IgM), and enzymes (e.g., lysozyme and lactoperoxidases) that play an important role in the maintenance of oral health and are the first line of defense of the host against pathogens such as Streptococcus mutans, Streptococcus sobrinus, and Streptococcus sanguis [1]. Other protective factors include saliva flow, buffering capacity of saliva, protective dietary components, and non-cariogenic sweeteners [2]. The capacity is based on the phosphate system, the carbonic acid system, and the bicarbonate system [3]. Disorders in the dynamic balance between pathological and protective factors lead to dental caries.

The various immunoglobulins can control the growth of cariogenic oral microflora [3]. One of them is secretory immunoglobulin A (sIgA), which plays the main role in prevention of dental caries by inhibition of bacterial adherence, inactivation of bacterial enzymes and toxins, or by acting in synergy with other factors such as lysozyme and lactoferrin [4–6]. Salivary sIgA differs from serum IgA by having a dimeric structure, compared to the monomeric structure of the latter [7].

Another protective factor in saliva is histatins. The predominant human histatins are histatin-1, histatin-3, and histatin-5 [8]. They exhibit cidal activities against a broad range of pathogenic fungi, including Candida albicans, Cryptococcus neoformans, and Aspergillus fumigates. These proteins may represent major components of the non-immune host defense system involved in the maintenance of oral health. Histatin-5 is a salivary peptide, which contains 24 amino acids and it has antifungal properties against the opportunistic yeast Candida albicans. The mechanism of action is still unclear but mitochondria seem to be the specific intracellular target leading to membrane damage and cell death [9–11]. Besides fungicidal and fungistatic properties, antibacterial properties have been attributed to histatins based on their killing and growth-inhibitory activity against several species of oral bacteria [12].

Salivary lactoperoxidase (LPO) is a protein with unique enzymatic activity. The main role of the enzyme is protection of salivary proteins from bacterial degradation. LPO works in conjunction with thiocyanate and hydrogen peroxide. The products of that interaction inhibit glucose metabolism and oxidize bacterial sulfhydryl groups [13].

The aim of the study was to compare sIgA, histatin-5, and lactoperoxidase levels between adolescents with low and high caries activity. There is no data about the level of these 3 specific components in saliva of adolescents with dental caries disease in a single study.

Material and Methods

STUDY POPULATION:

Thirty-five adolescents (age 18 years) from a high school were examined. Their caries intensity index DMF (decayed/missing/filled; D+M+F/number of the examined) was determined and the study population was then divided into 2 groups. Group I was composed of 8 adolescents with DMF=3 (low intensity of dental caries) and Group II was 27 adolescents with DMF>11 (high intensity of dental caries). All subjects had DMF higher than value 0. Clinical evaluation procedures were performed and included periodontal and mucosal status, evaluation of malocclusion, and collection of unstimulated whole saliva samples.

The research protocol was approved by the Committee for Ethics and Supervision on Human Research, Medical University of Bialystok, with informed consent from the patients.

SALIVA COLLECTION:

Unstimulated whole saliva was collected by a standard method into sterilized tubes, which were then placed on ice. Samples from the subjects were taken between 9:00 A.M and 11:00 A.M. Before collecting the saliva, all subjects abstained from eating and drinking for 2 h. Saliva samples were homogenized and clarified by centrifugation at 10 000 × g for 15 min at 4°C. The aliquots of clarified supernatants were kept at –70°C until needed for measurements.

ANALYSIS OF SALIVARY IGA:

The high-sensitivity assay kit (USCNK) was used to determine the level of sIgA in the saliva samples. The microtiter plates had been pre-coated with a monoclonal antibody specific to sIgA. Standards and samples were added to the appropriate microtiter plate wells and incubated for 1 h at room temperature. After washing away any unbound substances, peroxidase-labeled antibody was added to each microplate well and incubated for 1 h at room temperature. After another aspiration and washing step, a TMB substrate solution was added to each well. The enzyme-substrate reaction was terminated by the addition of a sulfuric acid solution and the color change was measured at a wavelength of 450 nm. The assay was performed in duplicate and the concentration of sIgA in the samples was then determined by comparing the O.D. of the samples to the standard curve.

DETERMINATION OF HISTATIN-5:

Saliva samples were determined by using an enzyme-linked immunosorbent assay kit (Cusabio Biotech Co., LTD.). The microtiter plate had been pre-coated with an antibody specific to histatin-5. Standards and samples (100 μL each) were pipetted into the wells in duplicate and incubated for 2 h at 37°C. After the incubation step, biotin-conjugated antibody working solution was added to each well. After washing away any unbound substances, avidin conjugated to horseradish peroxidase (HRP) working solution (100 μL) was added to each well for 1 h at 37°C. Then a substrate solution (90 μL) was added to the wells for 30 min; the color developed in proportion to the amount of histatin-5 bound in the initial step. Color development was stopped by sulfuric acid solution, and the intensity of the color was measured spectrophotometrically at a wavelength of 450 nm. The concentrations of histatin-5 in the samples were calculated from the standard curve.

DETERMINATION OF HUMAN LACTOPEROXIDASE (LPO):

Saliva samples were determined by using an enzyme-linked immunosorbent assay kit (Uscn Life Science, Inc.). The microtiter plate had been pre-coated with an antibody specific to LPO. Standards and samples (100 μL each) were then added into the wells in duplicate and incubated for 2 h at 37°C. After incubation, biotin-conjugated antibody working solution was added to each well. After washing away any unbound substances, avidin conjugated to horseradish peroxidase (HRP) working solution (100 μL) was added to each well for 1 h at 37°C. Then a TMB substrate solution (90 μL) was added to the wells for 30 min; the color developed in proportion to the amount of LPO bound in the initial step. Color development was stopped by addition of sulfuric acid solution, and the intensity of the color was measured spectrophotometrically at a wavelength of 450 nm. The minimum detectable dose (MDD) of human LPO was typically less than 8.1 nmol/L. The concentrations of histatin-5 in the samples were calculated from the standard curve.

STATISTICAL ANALYSIS:

The Mann-Whitney U nonparametric test for unrelated results of sIgA, histatin-5, and LPO was used to compare differences between the groups. All differences were considered significant when p<0.05. Statistical analysis was carried out using the Statistica 8.0 (StatSoft, USA).

Results

The salivary IgA, histatin-5, and LPO median and range of Group I and II are presented in Table 1. The minimum concentration of sIgA in Group I was 2.1 mg/dL and it was lower compared to minimal concentration in Group II (7.2 mg/dL). The maximum value of sIgA in Group I was 22.2 mg/dL and 23.8 mg/dL in Group II. Figure 1 shows the sIgA levels in both groups. The median of sIgA was 8.10 mg/dL in Group I and it was lower in comparison with adolescents from Group II, in which the median was 13 mg/dL. The difference was statistically significant (p=0.003, Table 1).

Figure 2 shows the histatin-5 levels in both groups. The median of histatin-5 was 16.89 ng/mL in Group I and 66.84 ng/mL in Group II, which had higher intensity of caries. The level of histatin-5 was significantly higher in Group II (p=0.015, Table 1). The minimum concentration of histatin-5 was 14.11 ng/mL in both groups, but the maximum concentration was higher in Group II, in which the value was 649 ng/mL (Table 1).

Results of LPO determination in groups are presented in Figure 3. The median of LPO was 2148 nmol/L in Group I and it was lower compared to Group II, in which the median of LPO was 3047 nmol/L. The difference was statistically significant (p=0.02, Table 1). The minimum and maximum was 1305 and 3248 nmol/L in Group I (with DMF=3). The values were lower compared to minimum (1515 nmol/L) and maximum (3313 nmol/L) in Group II (with DMF>11) (Table 1).

There was no significant Spearman’s correlation between analyzed salivary components (Tables 2 and 3).

Discussion

Dental caries is an infectious and is the most common disease affecting children and adolescents worldwide [14]. It is caused by many factors, but the main microbial cause of the disease is Streptococcus mutans, which possesses a very strong cariogenic potential. The literature reports a positive correlation between S. mutans and dental caries disease.

Saliva and its composition play a vital role in the immune defense against pathogenic bacteria and takes part in demineralization and remineralization of the tooth structure.

The major salivary components are immunoglobulins (sIgA), proteins (histatin-5), and enzymes (LPO). They have very strong antimicrobial properties. The aim of the study was to measure the levels of selected salivary components with bactericidal potential. Our results showed significantly higher levels of sIgA in unstimulated whole saliva of adolescents with high activity of caries compared to subjects with low caries activity.

Several studies reported different results regarding the concentration of sIgA in dental caries patients. Our results are similar to those reported by Thaweboon et al., Bruno et al., and de Farias et al. [15–17]. They demonstrated that increase in caries activity is associated with an increase of sIgA levels. Some studies have reported a correlation between levels of sIgA and the age of subjects. Jafarzadeh et al. observed age-dependent changes in salivary IgA, showing that mean sIgA levels were significantly higher in older subjects compared to subjects aged 1–10 years, although they proved that the mean level of sIgA slightly decreased in subjects aged 61–70 years [1]. Challacombe et al. showed higher levels of sIgA in older people [18]. Some authors have emphasized links between age-dependent changes in salivary IgA and changes in cytokine production. Recently, we have shown higher levels of pro-inflammatory cytokines (IL-6, IL-8, and TNF-α) and selected mucins in saliva of adolescents with high intensity of caries [19,20].

Bagharian et al. found higher levels of sIgA in the saliva of children who were colonized for less than 6 months with S. mutans and their DMF was lower compared to those who had harbored S. mutans for longer than 24 months and had high DMF score [21].

Histatins are a group of small, cationic, histidine-rich peptides secreted by human salivary glands. Histatins have antifungal and bactericidal activity, and have been shown to reduce the clinical signs of gingival inflammation and plaque formation. Researchers have investigated its possible role in periodontal disease. One study showed that the levels of histatin increase from health to periodontitis, but the levels of histatin in the gingival crevicular fluid and saliva had no correlation with severity of periodontal disease [22]. We observed higher levels of histatin-5 and LPO in adolescents with high intensity of caries. All differences were statistically significant.

Lactoperoxidase, a member of the mammalian heme peroxidase family, uses hydrogen peroxide (H2O2) to catalyze the oxidation of thiocyanate (SCN–) and produce hypothiocyanite (OSCN−), a biocidal compound [23]. The lactoperoxidase system is known to inhibit many Gram-negative bacteria, including H. pylori, in vitro [24]. Haukioja et al. proved that H. pylori strain ATCC 43504T and 5 clinical isolates were efficiently inhibited by the peroxidase system, with high concentrations of H2O2 in buffer. The inhibition was stronger at lower pH. However, in human saliva these high concentrations of H2O2 generated less hypothiocyanite, the antibacterial product of the peroxidase system, and the effects of the peroxidase system were weaker [25].

The effect of lactoperoxidase on the antimicrobial effectiveness was checked by Welk et al., who discovered that tested thiocyanate and H2O2 mixtures showed no relevant antimicrobial effect, but by adding LPO the mixtures they became effective bactericidal and fungicidal agents [26].

Our research proves that sIgA acts in conjunction with other salivary components. SIgA together with LPO and histatin-5 may enhance antibacterial properties. The network of interactions between salivary components needs further investigation.

Conclusions

We suggested that high-intensity caries is associated with increased levels of some salivary components – sIgA, histatin-5, and lactoperoxidase – that possess strong bactericidal or bacteriostatic effects resulting in aggregation of oral bacteria and their clearance from the oral cavity. More studies should be carried out to discover and explain molecular pathways involved in dental caries.

References

1. Jafarzadeh A, Sadeghi M, Karam GA, Vazirinejad R, Salivary IgA and IgE levels in healthy subjects: relation to age and gender: Braz Oral Res, 2010; 24; 21-27, pmid: 20339709

2. Featherstone JD, The continuum of dental caries-evidence for a dynamic disease process: J Dent Res, 2004; 83; 39-42

3. Kuriakose S, Sundaresan C, Mathai V, A comparative study of salivary buffering capacity, flow rate, resting pH, and salivary immunoglobulin A in children with rampant caries and caries-resistant children: J Indian Soc Pedod Prev Dent, 2013; 31; 69-73, pmid: 23886715

4. Ranadheer E, Nayak UA, Reddy NV, Rao VA, The relationship between salivary IgA levels and dental caries in children: J Indian Soc Pedod Prev Dent, 2011; 29; 106-12, pmid: 21911947

5. Chawda JG, Chaduvula N, Patel HR, Salivary sIgA and dental caries activity: Indian Pediatr, 2011; 48; 719-21, pmid: 21992904

6. Newbrun E, Current concepts of caries etiology: Cariology, 1978; 43, Baltimore, Williams and Wilkins

7. Shifa S, Muthu MS, Amarlal D, Rathna Prabhu V, Quantitative assessment of IgA levels in unstimulated whole saliva of caries-free and caries-active children: J Indian Soc Pedod Prevent Dent, 2008; 26; 158-61

8. Xu T, Levitz SM, Diamond RD, Oppenheim FG, Anticandidal activity of major human salivary histatins: Infect Immun, 1991; 59; 2549-54, pmid: 1855975

9. Helmerhorst EJ, Troxler RF, Oppenheim FG, The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species: Proc Natl Acad Sci USA, 2001; 98; 14637-42, pmid: 11717389

10. Khan SA, Fidel PL, Thunayyan AA, Impaired histatin-5 levels and salivary antimicrobial activity against C. albicans in HIV infected individuals: J AIDS Clin Res, 2013; 4; 1000193, pmid: 23730535

11. Edgerton M, Koshlukova SE, Salivary histatin 5 and its similarities to the other antimicrobial proteins in human saliva: Adv Dent Res, 2000; 14; 16-21, pmid: 11842919

12. Gusman H, Travis J, Helmerhorst EJ, Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease: Infect Immun, 2001; 69; 1402-8, pmid: 11179305

13. Hicks J, Garcia-Godoy F, Flaitz C, Biological factors in dental caries: role of saliva and dental plaque in the dynamic process of demineralization and remineralization (part1): J Clin Pediatr Dent, 2003; 28; 47-52, pmid: 14604142

14. Selwitz RH, Ismail AI, Pitts NB, Dental caries: Lancet, 2007; 369; 51-59, pmid: 17208642

15. Thaweboon S, Thaweboon B, Nakornchai S, Jitmaitree S, Salivary secretory IgA, pH, flow rates, mutans streptococci and Candida in children with rampant caries: Southeast Asian J Trop Med Public Health, 2008; 39; 893-99, pmid: 19058586

16. Bruno B, Pezzini A, Menegazzi M, Salivary levels of immunoglobulin and dental caries in children: Boll Soc Ital Biol Sper, 1985; 61; 381-86, pmid: 4027030

17. De Farias DG, Bezerra AC, Salivary antibodies, amylase and protein from children with early childhood caries: Clin Oral Investig, 2003; 7; 154-57

18. Challacombe SJ, Percival RS, Marsh PD, Age-related changes in immunoglobulin isotypes in whole and parotid saliva and serum in healthy individuals: Oral Microbiol Immunol, 1995; 10; 202-7, pmid: 8602331

19. Gornowicz A, Bielawska A, Bielawski K, Pro-inflammatory cytokines in saliva of adolescents with dental caries disease: Ann Agric Environ Med, 2012; 19; 711-16, pmid: 23311795

20. Gabryel-Porowska H, Gornowicz A, Bielawska A, Mucin levels in saliva of adolescents with dental caries: Med Sci Monit, 2014; 20; 72-77, pmid: 24441930

21. Bagherian A, Jafarzadeh A, Rezaeian M, Comparison of the salivary immunoglobulin concentration levels between children with early childhood caries and caries-free children: Iran J Immunol, 2008; 5; 217-21, pmid: 19098366

22. Bhadbhade SJ, Acharya AB, Thakur SL, Salivary and gingival crevicular fluid histatin in periodontal health and disease: J Clin Exp Dent, 2013; 5; 174-78

23. Fragoso MA, Torbati A, Fregien N, Conner GE, Molecular heterogeneity and alternative splicing of human lactoperoxidase: Arch Biochem Biophys, 2009; 482; 52-57, pmid: 19059195

24. Shin K, Yamauchi K, Teraguchi S: J Med Microbiol, 2002; 51; 231-37, pmid: 11871618

25. Haukioja A, Ihalin R, Loimaranta V: J Med Microbiol, 2004; 53; 855-60, pmid: 15314191

26. Welk A, Meller Ch, Schubert R, Effect of lactoperoxidase on the antimicrobial effectiveness of the thiocyanate hydrogen peroxide combination in a quantitative suspension test: BMC Microbiol, 2009; 9; 134, pmid: 19589149

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750